Artwork

Content provided by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 87 - The ULTIMATE-DAPT Trial and Empagliflozin after Acute Myocardial Infarction

19:58
 
Share
 

Manage episode 422172461 series 3381372
Content provided by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Welcome back Rounds Table Listeners!

We are back today with our Classic Rapid Fire Podcast!
This week, Drs. Mike and John Fralick discuss two recent papers exploring the role of ticagrelor with aspirin versus ticagrelor alone after percutaneous coronary intervention in acute MI and the efficacy of empagliflozin after acute MI. Two papers, here we go!

  1. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT) (0:00 – 9:22).
  2. Empagliflozin after Acute Myocardial Infarction (9:22 – 16:00).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

  continue reading

346 episodes

Artwork
iconShare
 
Manage episode 422172461 series 3381372
Content provided by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. John Fralick and Dr. Michael Fralick, Dr. John Fralick, and Dr. Michael Fralick or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Welcome back Rounds Table Listeners!

We are back today with our Classic Rapid Fire Podcast!
This week, Drs. Mike and John Fralick discuss two recent papers exploring the role of ticagrelor with aspirin versus ticagrelor alone after percutaneous coronary intervention in acute MI and the efficacy of empagliflozin after acute MI. Two papers, here we go!

  1. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT) (0:00 – 9:22).
  2. Empagliflozin after Acute Myocardial Infarction (9:22 – 16:00).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

  continue reading

346 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide